Skip to main content
Erschienen in: Endocrine 1/2008

01.04.2008 | Original Paper

Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study

verfasst von: Cihangir Erem, Arif Hacıhasanoglu, Orhan Deger, Murat Topbaş, Ilgın Hosver, Halil Onder Ersoz, Gamze Can

Erschienen in: Endocrine | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective In order to estimate the prevalence of metabolic syndrome (MetS) as defined by NCEP Adult Treatment Panel III (ATP III) criteria in the Trabzon Region and its associations with demographic factors (age, sex, marital status, reproductive history in women, and level of education), socioeconomic factors (household income and occupation), family history of selected medical conditions (diabetes, hypertension, and obesity), lifestyle factors (smoking habits, physical activity, and alcohol consumption) in the adult population. Research Methods and Procedures In this cross-sectional survey, a sample of households was systematically selected from the central province of Trabzon and its nine towns. A total of 4,809 adult subjects ≥20 years (2,601 women and 2,208 men) were included in the study. Blood pressure levels were measured for all subjects. The persons included in the questionnaire were invited to the local medical centers for blood examination between 08:00 and 10:00 following 12 h of fasting. Fasting serum glucose (FBG) levels and lipid profile were measured with autoanalyzer. MetS was defined according to guidelines from the NCEP ATP III diagnostic criteria. Results The prevalence of MetS was 26.9%: 31.3 in women and 21.7% in men. The prevalence increased with age, being highest in the 60–69-year-old age group (53.4%) but lower again in the ≥70 age group. MetS was associated positively with marital status, parity, cessation of cigarette smoking, and negatively with the level of education, alcohol consumption, current cigarette use, household income, and physical activity. Hypertension was found as the most common MetS component in our study (57.4%). Others in decreasing order were abdominal obesity (40.9%), low high-density lipoprotein-C (HDL-C) (31.8%), hypertriglyceridemia (30.7%), and high FBG levels (9.2%). Similarly, in the subjects diagnosed with MetS, HT had the highest prevalence (91.9%). This was followed by abdominal obesity (82.3%), hypertriglyceridemia (74%), low HDL-C (68.6%), and high fasting blood glucose levels (28.6%). Discussion MetS is moderately common and an important health problem in the adult population of Trabzon. In order to control MetS and its components, effective public health education and taking urgent steps are needed. These steps include serious education, providing a well-balanced diet and increasing physical activity.
Literatur
1.
Zurück zum Zitat P.J. Miranda, R.A. DeFronzo, R.M. Califf, J.R. Guyton, Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J. 149, 33–45 (2005)CrossRefPubMed P.J. Miranda, R.A. DeFronzo, R.M. Califf, J.R. Guyton, Metabolic syndrome: definition, pathophysiology, and mechanisms. Am. Heart J. 149, 33–45 (2005)CrossRefPubMed
2.
Zurück zum Zitat E. Ferrannini, S.M. Haffner, B.D. Mitchell, M.P. Stern, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416–422 (1991)CrossRefPubMed E. Ferrannini, S.M. Haffner, B.D. Mitchell, M.P. Stern, Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34, 416–422 (1991)CrossRefPubMed
3.
Zurück zum Zitat A. Fontbonne, Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia 37, 953–955 (1994)CrossRefPubMed A. Fontbonne, Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia 37, 953–955 (1994)CrossRefPubMed
4.
Zurück zum Zitat R.L. Hanson, G. Imperatore, P.H. Bennett, W.C. Knowler, Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 51, 3120–3127 (2002)CrossRefPubMed R.L. Hanson, G. Imperatore, P.H. Bennett, W.C. Knowler, Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 51, 3120–3127 (2002)CrossRefPubMed
5.
Zurück zum Zitat B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.R. Taskinen, L. Groop, Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689 (2001)CrossRefPubMed B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.R. Taskinen, L. Groop, Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689 (2001)CrossRefPubMed
6.
Zurück zum Zitat Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III). JAMA. 285, 2486–2497 (2001) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III). JAMA. 285, 2486–2497 (2001)
7.
Zurück zum Zitat S.W. Oh, Y.S. Yoon, E.S. Lee, W.K. Kim, Association between cigarette smoking and metabolic syndrome. Diabetes Care 28, 2064–2066 (2005)CrossRefPubMed S.W. Oh, Y.S. Yoon, E.S. Lee, W.K. Kim, Association between cigarette smoking and metabolic syndrome. Diabetes Care 28, 2064–2066 (2005)CrossRefPubMed
8.
Zurück zum Zitat Y.S. Yoon, S.W. Oh, H.W. Baik, H.S. Park, W.Y. Kim, Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 80, 217–224 (2004)PubMed Y.S. Yoon, S.W. Oh, H.W. Baik, H.S. Park, W.Y. Kim, Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am. J. Clin. Nutr. 80, 217–224 (2004)PubMed
9.
Zurück zum Zitat S. Yoo, T. Nicklas, T. Baranowski, I.F. Zakeri, S.J. Yang, S.R. Srinivasan, G.S. Berenson, Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: Bogalusa Heart Study. Am. J. Clin. Nutr. 80, 841–848 (2004)PubMed S. Yoo, T. Nicklas, T. Baranowski, I.F. Zakeri, S.J. Yang, S.R. Srinivasan, G.S. Berenson, Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: Bogalusa Heart Study. Am. J. Clin. Nutr. 80, 841–848 (2004)PubMed
10.
Zurück zum Zitat C.L. Scott, Diagnosis, prevention and intervention for the metabolic syndrome. Am. J. Cardiol. 92(Suppl), 35i–42i (2003) C.L. Scott, Diagnosis, prevention and intervention for the metabolic syndrome. Am. J. Cardiol. 92(Suppl), 35i–42i (2003)
11.
Zurück zum Zitat A.O. Rantala, H. Kauma, M. Lilja, M.J. Savolainen, A. Reunanen, Y.A. Kesaniemi, Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J. Intern. Med. 245, 163–174 (1999)CrossRefPubMed A.O. Rantala, H. Kauma, M. Lilja, M.J. Savolainen, A. Reunanen, Y.A. Kesaniemi, Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J. Intern. Med. 245, 163–174 (1999)CrossRefPubMed
12.
Zurück zum Zitat A.J. Cameron, J.E. Shaw, P.Z. Zimmet, The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. N. Am. 33, 351–375 (2004)CrossRef A.J. Cameron, J.E. Shaw, P.Z. Zimmet, The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. N. Am. 33, 351–375 (2004)CrossRef
13.
Zurück zum Zitat A. Gupta, R. Gupta, M. Sarna, S. Rastogi, V.P. Grupta, K. Kothari, Prevalence of diabetes, impaired fasting glucose and insulin resistence syndrome in an urban Indian population. Diabetes Res. Clin. Pract. 61, 69–76 (2003)CrossRefPubMed A. Gupta, R. Gupta, M. Sarna, S. Rastogi, V.P. Grupta, K. Kothari, Prevalence of diabetes, impaired fasting glucose and insulin resistence syndrome in an urban Indian population. Diabetes Res. Clin. Pract. 61, 69–76 (2003)CrossRefPubMed
14.
Zurück zum Zitat E.S. Ford, W.H. Giles, W.H. Dietz, Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356–359 (2002)CrossRefPubMed E.S. Ford, W.H. Giles, W.H. Dietz, Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356–359 (2002)CrossRefPubMed
15.
Zurück zum Zitat B. Balkau, M. Vernay, L. Mhamdi, M. Novak, D. Arondel, S. Vol, J. Ticket, E. Eschwege, The D.E.S.I.R study group, The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab. 29, 526–532 (2003)CrossRefPubMed B. Balkau, M. Vernay, L. Mhamdi, M. Novak, D. Arondel, S. Vol, J. Ticket, E. Eschwege, The D.E.S.I.R study group, The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab. 29, 526–532 (2003)CrossRefPubMed
16.
Zurück zum Zitat A. Ramachandran, C. Snehalatha, K. Satyavani, S. Sivasankari, V. Vijay, Metabolic syndrome in urban Asian Indian Adults—a population study using modified ATP III criteria. Diabetes Res. Clin. Pract. 60, 199–204 (2003)CrossRefPubMed A. Ramachandran, C. Snehalatha, K. Satyavani, S. Sivasankari, V. Vijay, Metabolic syndrome in urban Asian Indian Adults—a population study using modified ATP III criteria. Diabetes Res. Clin. Pract. 60, 199–204 (2003)CrossRefPubMed
17.
Zurück zum Zitat C. Erem, C. Arslan, A. Hacihasanoglu, O. Deger, M. Topbaş, K. Ukinc, H.Ö. Ersöz , M. Telatar, Prevalence of obesity and associated risk factors in a Turkish population (Trabzon City, Turkey). Obes. Res. 12, 1117–1127 (2004)CrossRefPubMed C. Erem, C. Arslan, A. Hacihasanoglu, O. Deger, M. Topbaş, K. Ukinc, H.Ö. Ersöz , M. Telatar, Prevalence of obesity and associated risk factors in a Turkish population (Trabzon City, Turkey). Obes. Res. 12, 1117–1127 (2004)CrossRefPubMed
18.
Zurück zum Zitat C. Erem, R. Yıldız, H. Kavgacı, C. Karahan, O. Değer, G. Çan, M. Telatar, Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon City). Diabetes Res. Clin. Pract. 54, 203–208 (2001)CrossRefPubMed C. Erem, R. Yıldız, H. Kavgacı, C. Karahan, O. Değer, G. Çan, M. Telatar, Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon City). Diabetes Res. Clin. Pract. 54, 203–208 (2001)CrossRefPubMed
19.
Zurück zum Zitat I. Satman, T. Yilmaz, A. Sengul, S. Salman, F. Salman, S. Uygur, I. Bastar, Y. Tutuncu, M. Sargin, N. Dinccag, K. Karsidag, S. Kalaca, C. Ozcan, H. King, The TURDEP Group, Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 25, 1551–1556 (2002)CrossRefPubMed I. Satman, T. Yilmaz, A. Sengul, S. Salman, F. Salman, S. Uygur, I. Bastar, Y. Tutuncu, M. Sargin, N. Dinccag, K. Karsidag, S. Kalaca, C. Ozcan, H. King, The TURDEP Group, Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 25, 1551–1556 (2002)CrossRefPubMed
20.
Zurück zum Zitat A. Onat, K. Ceyhan, O. Basar, S. Toprak, V. Sansoy, Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis 165, 285–292 (2002)CrossRefPubMed A. Onat, K. Ceyhan, O. Basar, S. Toprak, V. Sansoy, Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis 165, 285–292 (2002)CrossRefPubMed
21.
Zurück zum Zitat A.K. Ozsahin, A. Gökcel, N. Sezgin, M. Akbaba, N. Güvener, I. Ozisik, B.M. Karademir, Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr. Metab. 17, 230–234 (2004)PubMed A.K. Ozsahin, A. Gökcel, N. Sezgin, M. Akbaba, N. Güvener, I. Ozisik, B.M. Karademir, Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr. Metab. 17, 230–234 (2004)PubMed
22.
Zurück zum Zitat M.I. Schmidt, B.B. Duncan, R.L. Watson, A.R. Sharrett, F.L. Brancati, G. Heiss, A metabolic syndrome in whites and African-Americans: the atherosclerosis risk in communities baseline study. Diabetes Care 19, 414–418 (1996)CrossRefPubMed M.I. Schmidt, B.B. Duncan, R.L. Watson, A.R. Sharrett, F.L. Brancati, G. Heiss, A metabolic syndrome in whites and African-Americans: the atherosclerosis risk in communities baseline study. Diabetes Care 19, 414–418 (1996)CrossRefPubMed
23.
Zurück zum Zitat K. Gu Dongfeng Reynolds, X. Wu, J. Chen, X. Duan, R.F. Reynolds, P.K. Whelton, J. He, The interASIA Collaborative Group, Prevalence of the metabolic syndrome and overweight among adults in Chine. Lancet 365, 1398–1405 (2005)CrossRef K. Gu Dongfeng Reynolds, X. Wu, J. Chen, X. Duan, R.F. Reynolds, P.K. Whelton, J. He, The interASIA Collaborative Group, Prevalence of the metabolic syndrome and overweight among adults in Chine. Lancet 365, 1398–1405 (2005)CrossRef
24.
Zurück zum Zitat L.N.T.D. Son, D. Kunii, N.T.K. Hung, T. Sakai, S. Yamamoto, The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabetes Res. Clin. Pract. 67, 243–250 (2005)CrossRef L.N.T.D. Son, D. Kunii, N.T.K. Hung, T. Sakai, S. Yamamoto, The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabetes Res. Clin. Pract. 67, 243–250 (2005)CrossRef
25.
Zurück zum Zitat F. Azizi, P. Salehi, A. Etemadi, S. Zahedi-Asl, Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res. Clin. Pract. 61, 29–37 (2003)CrossRefPubMed F. Azizi, P. Salehi, A. Etemadi, S. Zahedi-Asl, Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res. Clin. Pract. 61, 29–37 (2003)CrossRefPubMed
26.
Zurück zum Zitat V.G. Athyros, V.I. Bouloukos, A.N. Pehlivanidis, A.A. Papageorgiou, S.G. Dionysopoulou, A.N. Symeonidis, D.I. Petridis, M.I. Kapousouzi, E.A. Satsoglou, Mikhailidis DP, The MetS-Greece Collabotarive Group, The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study. Diabetes Obes. Metab. 7, 397–405 (2005) V.G. Athyros, V.I. Bouloukos, A.N. Pehlivanidis, A.A. Papageorgiou, S.G. Dionysopoulou, A.N. Symeonidis, D.I. Petridis, M.I. Kapousouzi, E.A. Satsoglou, Mikhailidis DP, The MetS-Greece Collabotarive Group, The prevalence of the metabolic syndrome in Greece: The MetS-Greece Multicentre Study. Diabetes Obes. Metab. 7, 397–405 (2005)
27.
Zurück zum Zitat F.E.R. Punzalan, R.G. Sy, T. Ty-Willing, Prevalence of metabolic syndrome among adult Filipinos. Int. Congr. Ser. 1262, 442–445 (2004)CrossRef F.E.R. Punzalan, R.G. Sy, T. Ty-Willing, Prevalence of metabolic syndrome among adult Filipinos. Int. Congr. Ser. 1262, 442–445 (2004)CrossRef
28.
Zurück zum Zitat R. Gupta, P.C. Deedwania, A. Gupta, S. Rastogi, R.B. Panwar, K. Kothari, Prevalence of metabolic syndrome in an Indian urban population. Int. J. Cardiol. 97, 257–261 (2004)CrossRefPubMed R. Gupta, P.C. Deedwania, A. Gupta, S. Rastogi, R.B. Panwar, K. Kothari, Prevalence of metabolic syndrome in an Indian urban population. Int. J. Cardiol. 97, 257–261 (2004)CrossRefPubMed
29.
Zurück zum Zitat W.-Y. Lee, J.-S. Park, S.-Y. Noh, E.-J. Rhee, S.-W. Kim, P.Z. Zimmet, Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res. Clin. Pract. 65, 143–149 (2004)CrossRefPubMed W.-Y. Lee, J.-S. Park, S.-Y. Noh, E.-J. Rhee, S.-W. Kim, P.Z. Zimmet, Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res. Clin. Pract. 65, 143–149 (2004)CrossRefPubMed
30.
Zurück zum Zitat R. Miccoli, C. Bianchi, L. Odoguardi, G. Penno, F. Caricato, M.G. Giovannitti, L. Pucci, S. Del Prato, Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr. Metab. Cardiovasc. Dis. 15, 250–254 (2005)CrossRefPubMed R. Miccoli, C. Bianchi, L. Odoguardi, G. Penno, F. Caricato, M.G. Giovannitti, L. Pucci, S. Del Prato, Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr. Metab. Cardiovasc. Dis. 15, 250–254 (2005)CrossRefPubMed
31.
Zurück zum Zitat H.S. Park, S.W. Oh, S.-I. Cho, W.H. Choi, Y.S. Kim, The metabolic syndrome and associated lifestyle factors among South Korean adults. Int. J. Epidemiol. 33, 328–336 (2004)CrossRefPubMed H.S. Park, S.W. Oh, S.-I. Cho, W.H. Choi, Y.S. Kim, The metabolic syndrome and associated lifestyle factors among South Korean adults. Int. J. Epidemiol. 33, 328–336 (2004)CrossRefPubMed
32.
Zurück zum Zitat C.A. Aguilar-Salinas, R. Rojas, F.J. Gomez-Perez, V. Valles, J.M. Rios-Torres, A. Franco, G. Olaiz, J.A. Rull, J. Sepulveda, High prevalence of metabolic syndrome in Mexico. Arch. Med. Res. 35, 76–81 (2004)CrossRefPubMed C.A. Aguilar-Salinas, R. Rojas, F.J. Gomez-Perez, V. Valles, J.M. Rios-Torres, A. Franco, G. Olaiz, J.A. Rull, J. Sepulveda, High prevalence of metabolic syndrome in Mexico. Arch. Med. Res. 35, 76–81 (2004)CrossRefPubMed
33.
Zurück zum Zitat J.-Y. Oh, Y.S. Hong, Y.-A. Sung, E. Barrett-Connor, Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Dibetes Care 27, 2027–2032 (2004)CrossRef J.-Y. Oh, Y.S. Hong, Y.-A. Sung, E. Barrett-Connor, Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Dibetes Care 27, 2027–2032 (2004)CrossRef
34.
Zurück zum Zitat WHO, Obesity: preventing and managing the global epidemic (WHO, Geneva, 1998) WHO, Obesity: preventing and managing the global epidemic (WHO, Geneva, 1998)
35.
Zurück zum Zitat J. Lidfeldt, P. Nyberg, C. Nerbrand, G. Samsione, B. Schersten, C.D. Agardh, Socio-demogaphic and psychosocial factors are associated with features of the metabolic syndrome. The Women’s Health in the Lund Area (WHILA) study. Diabetes Obes. Metab. 5, 106–112 (2003)CrossRefPubMed J. Lidfeldt, P. Nyberg, C. Nerbrand, G. Samsione, B. Schersten, C.D. Agardh, Socio-demogaphic and psychosocial factors are associated with features of the metabolic syndrome. The Women’s Health in the Lund Area (WHILA) study. Diabetes Obes. Metab. 5, 106–112 (2003)CrossRefPubMed
36.
Zurück zum Zitat S.P. Wamala, J. Lynch, M. Horsten, M.A. Mittleman, K. Schenck-Gustafsson, K. Orth-Gomer, Education and the metabolic syndrome in women. Diabetes Care 22, 1999–2003 (1999)CrossRefPubMed S.P. Wamala, J. Lynch, M. Horsten, M.A. Mittleman, K. Schenck-Gustafsson, K. Orth-Gomer, Education and the metabolic syndrome in women. Diabetes Care 22, 1999–2003 (1999)CrossRefPubMed
37.
Zurück zum Zitat R. Choiniere, P. Lafontaine, A.C. Edwards, Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. Can. Med. Assoc. J. 162, S13–S24 (2000) R. Choiniere, P. Lafontaine, A.C. Edwards, Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. Can. Med. Assoc. J. 162, S13–S24 (2000)
38.
Zurück zum Zitat A.M. Rissanen, M. Heliovaara, P. Knekt, A. Reunanen, A. Aromaa, Determinants of weight gain and overweight in adult Finns. Eur. J. Clin. Nutr. 45, 419–430 (1991)PubMed A.M. Rissanen, M. Heliovaara, P. Knekt, A. Reunanen, A. Aromaa, Determinants of weight gain and overweight in adult Finns. Eur. J. Clin. Nutr. 45, 419–430 (1991)PubMed
39.
Zurück zum Zitat Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163, 427–436 (2003)CrossRefPubMed Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield, The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch. Intern. Med. 163, 427–436 (2003)CrossRefPubMed
40.
Zurück zum Zitat T.M. Tahtinen, M.J. Vanhala, J.A. Oikarinen, S.M. Keinanen-Kiukaanniemi, Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J. Cardiovasc. Risk. 5, 319–323 (1998)CrossRefPubMed T.M. Tahtinen, M.J. Vanhala, J.A. Oikarinen, S.M. Keinanen-Kiukaanniemi, Effect of smoking on the prevalence of insulin resistance-associated cardiovascular risk factors among Finnish men in military service. J. Cardiovasc. Risk. 5, 319–323 (1998)CrossRefPubMed
41.
Zurück zum Zitat S. Attvall, J. Fowelin, I. Lager, H. Von Schenck, U. Smith, Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J. Intern. Med. 233, 327–332 (1993)CrossRefPubMed S. Attvall, J. Fowelin, I. Lager, H. Von Schenck, U. Smith, Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J. Intern. Med. 233, 327–332 (1993)CrossRefPubMed
42.
Zurück zum Zitat F.S. Facchini, C.B. Hollenbeck, J. Jeppesen, Y.D. Chen, G.M. Reaven, Insulin resistance and cigarette smoking. Lancet 339, 1128–1130 (1992)CrossRefPubMed F.S. Facchini, C.B. Hollenbeck, J. Jeppesen, Y.D. Chen, G.M. Reaven, Insulin resistance and cigarette smoking. Lancet 339, 1128–1130 (1992)CrossRefPubMed
43.
Zurück zum Zitat C. Kong, L. Nimmo, T. Elatrozy, V. Anyaoku, C. Hughes, S. Robinson, W. Richmond, R.S. Elkeles, Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis 156, 373–378 (2002)CrossRef C. Kong, L. Nimmo, T. Elatrozy, V. Anyaoku, C. Hughes, S. Robinson, W. Richmond, R.S. Elkeles, Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis 156, 373–378 (2002)CrossRef
44.
Zurück zum Zitat A.S. Leon, J. Connett, D.R. Jacobs Jr., R. Rauramaa, Leisure-time physical activity levels and risk of coronary heart disease and death: the Multiple Risk Factor Intervention Trial. JAMA 258, 2388–2395 (1987)CrossRefPubMed A.S. Leon, J. Connett, D.R. Jacobs Jr., R. Rauramaa, Leisure-time physical activity levels and risk of coronary heart disease and death: the Multiple Risk Factor Intervention Trial. JAMA 258, 2388–2395 (1987)CrossRefPubMed
45.
Zurück zum Zitat J. Pekkanen, B. Marti, A. Nissinen, J. Tuomilehto, S. Punsar, M.J. Karvonen, Reduction of premature mortality by high physical activity: a 20-year follow-up of middle-aged Finnish men. Lancet 255, 1473–1477 (1987)CrossRef J. Pekkanen, B. Marti, A. Nissinen, J. Tuomilehto, S. Punsar, M.J. Karvonen, Reduction of premature mortality by high physical activity: a 20-year follow-up of middle-aged Finnish men. Lancet 255, 1473–1477 (1987)CrossRef
46.
Zurück zum Zitat P.S. Denker, V.E. Pollock, Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch. Intern. Med. 152, 1649–1651 (1992)CrossRefPubMed P.S. Denker, V.E. Pollock, Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch. Intern. Med. 152, 1649–1651 (1992)CrossRefPubMed
47.
Zurück zum Zitat World Health Organization, The World Health Report 2000: Health System Efficiency (WHO, Geneva, 2000) World Health Organization, The World Health Report 2000: Health System Efficiency (WHO, Geneva, 2000)
48.
Zurück zum Zitat R. Ross, D. Dagnone, P.J. Jones, H. Smith, A. Paddags, R. Hudson, I. Janssen, Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, cotrolled trial. Ann. Intern. Med. 133, 92–103 (2000)PubMed R. Ross, D. Dagnone, P.J. Jones, H. Smith, A. Paddags, R. Hudson, I. Janssen, Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, cotrolled trial. Ann. Intern. Med. 133, 92–103 (2000)PubMed
Metadaten
Titel
Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study
verfasst von
Cihangir Erem
Arif Hacıhasanoglu
Orhan Deger
Murat Topbaş
Ilgın Hosver
Halil Onder Ersoz
Gamze Can
Publikationsdatum
01.04.2008
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2008
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-008-9044-3

Weitere Artikel der Ausgabe 1/2008

Endocrine 1/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.